NEOGEN CORP

Neogen Corporation announced its first-quarter financial results for fiscal year 2027, reporting a 6.5% increase in revenue to $222.8 million, with core revenue growth of 8.1%. The company posted a net loss of $11.9 million, or $(0.05) per share, compared to a net income of $36.3 million in the prior year, primarily due to a gain on divestiture in the previous period. However, Adjusted Net Income was $17.5 million, or $0.08 per share. Neogen is raising its fiscal year 2027 financial guidance for both revenue and Adjusted EBITDA, reflecting positive operational momentum and strategic initiatives including a collaboration with Hinalea Imaging Corp.

Neogen Corporation announced that Mr. Thierry Bernard resigned from its Board of Directors. The resignation became effective on August 3, 2026, as reported in the company's recent 8-K filing.

NEOGEN Corporation announced the planned divestment of its Genomics business to Zoetis Inc. for $160.0 million, with the transaction currently undergoing regulatory review. This follows the divestment of its global Cleaners and Disinfectants business in July 2025. The company also reported that international sales contributed significantly, accounting for 51.2% of total revenues in fiscal year 2026.

Neogen Corporation reported fiscal fourth quarter 2026 revenue of $225.3 million, a slight decrease of 0.1% but with core growth of 4.3%. Full fiscal year 2026 revenue was $870.4 million, down 2.7% with 1.9% core growth. The company achieved a net loss of $(11.3) million for the quarter, but an Adjusted Net Income of $18.7 million and Adjusted EBITDA of $45.4 million. Neogen also provided FY27 financial guidance, projecting revenue between $880 million and $885 million, and is on track with its Petrifilm manufacturing transition and the divestiture of its Genomics business.

NEOGEN CORP (NEOG) has filed its quarterly report for the period ended February 28, 2026. The filing confirms the company's status as a large accelerated filer and its compliance with SEC reporting requirements. As of the reporting date, the company had 217,673,041 shares of common stock outstanding. The full report, which includes interim condensed consolidated financial statements and management's discussion and analysis, will provide detailed insights into the company's performance for the quarter.

Neogen Corporation announced its third-quarter fiscal year 2026 results, reporting $211.2 million in revenue and a GAAP net loss of $17.0 million, or $(0.08) per share. While Food Safety revenue saw a 2.6% increase, the Animal Safety segment experienced a significant 20.1% decline, primarily attributed to third-party supplier challenges during the quarter. Despite the GAAP loss, the company achieved an Adjusted Net Income of $19.4 million and Adjusted EPS of $0.09, alongside a sequential improvement in Adjusted EBITDA margins to 22.8%. The company also generated $22.7 million in cash flow from operations, indicating underlying operational strength despite segment-specific headwinds.